nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—CYP1A1—lung cancer	0.188	0.653	CbGaD
Propranolol—ABCB1—lung cancer	0.1	0.347	CbGaD
Propranolol—ORM1—Gefitinib—lung cancer	0.0488	0.0952	CbGbCtD
Propranolol—ORM1—Erlotinib—lung cancer	0.0288	0.0563	CbGbCtD
Propranolol—CYP1A1—Gefitinib—lung cancer	0.0275	0.0536	CbGbCtD
Propranolol—SLC22A2—Vinblastine—lung cancer	0.0191	0.0374	CbGbCtD
Propranolol—SLC22A2—Cisplatin—lung cancer	0.0175	0.0343	CbGbCtD
Propranolol—CYP3A5—Gefitinib—lung cancer	0.0165	0.0322	CbGbCtD
Propranolol—CYP1A1—Erlotinib—lung cancer	0.0162	0.0317	CbGbCtD
Propranolol—CYP3A5—Teniposide—lung cancer	0.016	0.0312	CbGbCtD
Propranolol—CYP2C19—Gefitinib—lung cancer	0.0133	0.026	CbGbCtD
Propranolol—CYP2C19—Teniposide—lung cancer	0.0129	0.0252	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0119	0.0232	CbGbCtD
Propranolol—CYP3A7—Paclitaxel—lung cancer	0.0119	0.0232	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0117	0.0229	CbGbCtD
Propranolol—CYP3A7—Irinotecan—lung cancer	0.0117	0.0229	CbGbCtD
Propranolol—ABCB1—Topotecan—lung cancer	0.0117	0.0229	CbGbCtD
Propranolol—ABCB1—Gefitinib—lung cancer	0.0107	0.0209	CbGbCtD
Propranolol—CYP2D6—Gefitinib—lung cancer	0.0101	0.0197	CbGbCtD
Propranolol—CYP3A5—Crizotinib—lung cancer	0.0101	0.0197	CbGbCtD
Propranolol—CYP3A5—Erlotinib—lung cancer	0.00975	0.019	CbGbCtD
Propranolol—CYP3A5—Paclitaxel—lung cancer	0.00892	0.0174	CbGbCtD
Propranolol—CYP3A5—Irinotecan—lung cancer	0.0088	0.0172	CbGbCtD
Propranolol—CYP3A7—Docetaxel—lung cancer	0.0086	0.0168	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.0086	0.0168	CbGbCtD
Propranolol—ABCB1—Vinorelbine—lung cancer	0.00827	0.0161	CbGbCtD
Propranolol—CYP2D6—Vinorelbine—lung cancer	0.00779	0.0152	CbGbCtD
Propranolol—CYP1A2—Erlotinib—lung cancer	0.00726	0.0142	CbGbCtD
Propranolol—CYP3A5—Etoposide—lung cancer	0.00705	0.0138	CbGbCtD
Propranolol—CYP3A4—Topotecan—lung cancer	0.00703	0.0137	CbGbCtD
Propranolol—ABCB1—Crizotinib—lung cancer	0.00658	0.0128	CbGbCtD
Propranolol—CYP3A5—Docetaxel—lung cancer	0.00645	0.0126	CbGbCtD
Propranolol—CYP3A4—Gefitinib—lung cancer	0.00643	0.0126	CbGbCtD
Propranolol—ABCB1—Gemcitabine—lung cancer	0.00643	0.0125	CbGbCtD
Propranolol—ABCB1—Erlotinib—lung cancer	0.00634	0.0124	CbGbCtD
Propranolol—CYP3A4—Teniposide—lung cancer	0.00623	0.0122	CbGbCtD
Propranolol—CYP2D6—Erlotinib—lung cancer	0.00598	0.0117	CbGbCtD
Propranolol—ABCB1—Paclitaxel—lung cancer	0.00581	0.0113	CbGbCtD
Propranolol—ABCB1—Irinotecan—lung cancer	0.00573	0.0112	CbGbCtD
Propranolol—CYP1A2—Etoposide—lung cancer	0.00525	0.0102	CbGbCtD
Propranolol—ABCB1—Vinblastine—lung cancer	0.00509	0.00995	CbGbCtD
Propranolol—CYP3A4—Vinorelbine—lung cancer	0.00495	0.00967	CbGbCtD
Propranolol—CYP2D6—Vinblastine—lung cancer	0.0048	0.00937	CbGbCtD
Propranolol—ABCB1—Cisplatin—lung cancer	0.00467	0.00912	CbGbCtD
Propranolol—ABCB1—Etoposide—lung cancer	0.00459	0.00896	CbGbCtD
Propranolol—ABCB1—Docetaxel—lung cancer	0.0042	0.0082	CbGbCtD
Propranolol—CYP3A4—Crizotinib—lung cancer	0.00394	0.00769	CbGbCtD
Propranolol—CYP3A4—Erlotinib—lung cancer	0.0038	0.00742	CbGbCtD
Propranolol—CYP3A4—Paclitaxel—lung cancer	0.00348	0.00679	CbGbCtD
Propranolol—CYP3A4—Irinotecan—lung cancer	0.00343	0.0067	CbGbCtD
Propranolol—ABCB1—Doxorubicin—lung cancer	0.00313	0.00611	CbGbCtD
Propranolol—CYP3A4—Vinblastine—lung cancer	0.00305	0.00596	CbGbCtD
Propranolol—ABCB1—Methotrexate—lung cancer	0.00303	0.00592	CbGbCtD
Propranolol—CYP2D6—Doxorubicin—lung cancer	0.00295	0.00576	CbGbCtD
Propranolol—CYP3A4—Etoposide—lung cancer	0.00275	0.00537	CbGbCtD
Propranolol—CYP3A4—Docetaxel—lung cancer	0.00252	0.00491	CbGbCtD
Propranolol—CYP3A4—Doxorubicin—lung cancer	0.00188	0.00366	CbGbCtD
Propranolol—Carvedilol—HIF1A—lung cancer	0.00071	0.392	CrCbGaD
Propranolol—Carvedilol—VEGFA—lung cancer	0.000286	0.158	CrCbGaD
Propranolol—Atenolol—ABCB1—lung cancer	0.000142	0.0783	CrCbGaD
Propranolol—Carvedilol—CYP2E1—lung cancer	0.00014	0.0772	CrCbGaD
Propranolol—Carvedilol—CYP1A1—lung cancer	0.000138	0.0762	CrCbGaD
Propranolol—Acebutolol—ABCB1—lung cancer	0.000131	0.0722	CrCbGaD
Propranolol—Infection—Cisplatin—lung cancer	0.00012	0.00101	CcSEcCtD
Propranolol—Vomiting—Topotecan—lung cancer	0.00012	0.00101	CcSEcCtD
Propranolol—Hypoglycaemia—Doxorubicin—lung cancer	0.00012	0.00101	CcSEcCtD
Propranolol—Paraesthesia—Irinotecan—lung cancer	0.000119	0.00101	CcSEcCtD
Propranolol—Vertigo—Paclitaxel—lung cancer	0.000119	0.00101	CcSEcCtD
Propranolol—Lethargy—Doxorubicin—lung cancer	0.000119	0.001	CcSEcCtD
Propranolol—Rash—Topotecan—lung cancer	0.000119	0.001	CcSEcCtD
Propranolol—Hypersensitivity—Vinorelbine—lung cancer	0.000119	0.001	CcSEcCtD
Propranolol—Dermatitis—Topotecan—lung cancer	0.000119	0.001	CcSEcCtD
Propranolol—Vomiting—Erlotinib—lung cancer	0.000119	0.000998	CcSEcCtD
Propranolol—Dyspnoea—Irinotecan—lung cancer	0.000119	0.000998	CcSEcCtD
Propranolol—Nervous system disorder—Cisplatin—lung cancer	0.000118	0.000997	CcSEcCtD
Propranolol—Cough—Etoposide—lung cancer	0.000118	0.000996	CcSEcCtD
Propranolol—Somnolence—Irinotecan—lung cancer	0.000118	0.000995	CcSEcCtD
Propranolol—Rash—Erlotinib—lung cancer	0.000118	0.00099	CcSEcCtD
Propranolol—Dermatitis—Erlotinib—lung cancer	0.000118	0.000989	CcSEcCtD
Propranolol—Convulsion—Etoposide—lung cancer	0.000117	0.000989	CcSEcCtD
Propranolol—Skin disorder—Cisplatin—lung cancer	0.000117	0.000987	CcSEcCtD
Propranolol—Insomnia—Gemcitabine—lung cancer	0.000117	0.000986	CcSEcCtD
Propranolol—Dyspepsia—Irinotecan—lung cancer	0.000117	0.000986	CcSEcCtD
Propranolol—Paraesthesia—Gemcitabine—lung cancer	0.000116	0.000979	CcSEcCtD
Propranolol—Cough—Paclitaxel—lung cancer	0.000116	0.000976	CcSEcCtD
Propranolol—Asthenia—Vinorelbine—lung cancer	0.000116	0.000974	CcSEcCtD
Propranolol—Decreased appetite—Irinotecan—lung cancer	0.000116	0.000973	CcSEcCtD
Propranolol—Dyspnoea—Gemcitabine—lung cancer	0.000116	0.000972	CcSEcCtD
Propranolol—Nausea—Vinblastine—lung cancer	0.000115	0.00097	CcSEcCtD
Propranolol—Somnolence—Gemcitabine—lung cancer	0.000115	0.00097	CcSEcCtD
Propranolol—Convulsion—Paclitaxel—lung cancer	0.000115	0.000969	CcSEcCtD
Propranolol—Affect lability—Doxorubicin—lung cancer	0.000115	0.000967	CcSEcCtD
Propranolol—Gastrointestinal disorder—Irinotecan—lung cancer	0.000115	0.000967	CcSEcCtD
Propranolol—Fatigue—Irinotecan—lung cancer	0.000115	0.000965	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000115	0.000965	CcSEcCtD
Propranolol—Alopecia—Docetaxel—lung cancer	0.000114	0.000963	CcSEcCtD
Propranolol—Constipation—Irinotecan—lung cancer	0.000114	0.000957	CcSEcCtD
Propranolol—Pain—Irinotecan—lung cancer	0.000114	0.000957	CcSEcCtD
Propranolol—Mental disorder—Docetaxel—lung cancer	0.000113	0.000954	CcSEcCtD
Propranolol—Erythema—Docetaxel—lung cancer	0.000113	0.000948	CcSEcCtD
Propranolol—Decreased appetite—Gemcitabine—lung cancer	0.000113	0.000948	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000112	0.000946	CcSEcCtD
Propranolol—Nausea—Topotecan—lung cancer	0.000112	0.000943	CcSEcCtD
Propranolol—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000112	0.000942	CcSEcCtD
Propranolol—Fatigue—Gemcitabine—lung cancer	0.000112	0.00094	CcSEcCtD
Propranolol—Cardiac arrest—Doxorubicin—lung cancer	0.000111	0.000935	CcSEcCtD
Propranolol—Pain—Gemcitabine—lung cancer	0.000111	0.000933	CcSEcCtD
Propranolol—Constipation—Gemcitabine—lung cancer	0.000111	0.000933	CcSEcCtD
Propranolol—Nausea—Erlotinib—lung cancer	0.000111	0.000933	CcSEcCtD
Propranolol—Anaphylactic shock—Etoposide—lung cancer	0.000111	0.000931	CcSEcCtD
Propranolol—Mood swings—Doxorubicin—lung cancer	0.000111	0.000931	CcSEcCtD
Propranolol—Metoprolol—ABCB1—lung cancer	0.000111	0.061	CrCbGaD
Propranolol—Diarrhoea—Vinorelbine—lung cancer	0.00011	0.000929	CcSEcCtD
Propranolol—Infection—Etoposide—lung cancer	0.00011	0.000925	CcSEcCtD
Propranolol—Neutropenia—Methotrexate—lung cancer	0.000109	0.000917	CcSEcCtD
Propranolol—Gastrointestinal pain—Irinotecan—lung cancer	0.000109	0.000916	CcSEcCtD
Propranolol—Anaphylactic shock—Paclitaxel—lung cancer	0.000109	0.000913	CcSEcCtD
Propranolol—Paraesthesia—Cisplatin—lung cancer	0.000108	0.000913	CcSEcCtD
Propranolol—Infection—Paclitaxel—lung cancer	0.000108	0.000907	CcSEcCtD
Propranolol—Dyspnoea—Cisplatin—lung cancer	0.000108	0.000906	CcSEcCtD
Propranolol—Skin disorder—Etoposide—lung cancer	0.000107	0.000905	CcSEcCtD
Propranolol—Erectile dysfunction—Methotrexate—lung cancer	0.000107	0.000904	CcSEcCtD
Propranolol—Dizziness—Vinorelbine—lung cancer	0.000107	0.000898	CcSEcCtD
Propranolol—Nervous system disorder—Paclitaxel—lung cancer	0.000106	0.000896	CcSEcCtD
Propranolol—Skin disorder—Paclitaxel—lung cancer	0.000105	0.000887	CcSEcCtD
Propranolol—Abdominal pain—Irinotecan—lung cancer	0.000105	0.000885	CcSEcCtD
Propranolol—Body temperature increased—Irinotecan—lung cancer	0.000105	0.000885	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000105	0.000885	CcSEcCtD
Propranolol—Decreased appetite—Cisplatin—lung cancer	0.000105	0.000884	CcSEcCtD
Propranolol—Gastrointestinal disorder—Cisplatin—lung cancer	0.000104	0.000878	CcSEcCtD
Propranolol—Infestation NOS—Methotrexate—lung cancer	0.000104	0.000875	CcSEcCtD
Propranolol—Infestation—Methotrexate—lung cancer	0.000104	0.000875	CcSEcCtD
Propranolol—Depression—Methotrexate—lung cancer	0.000104	0.000872	CcSEcCtD
Propranolol—Pain—Cisplatin—lung cancer	0.000103	0.000869	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000103	0.000867	CcSEcCtD
Propranolol—Vomiting—Vinorelbine—lung cancer	0.000103	0.000863	CcSEcCtD
Propranolol—Body temperature increased—Gemcitabine—lung cancer	0.000102	0.000862	CcSEcCtD
Propranolol—Rash—Vinorelbine—lung cancer	0.000102	0.000856	CcSEcCtD
Propranolol—Dermatitis—Vinorelbine—lung cancer	0.000102	0.000855	CcSEcCtD
Propranolol—Paraesthesia—Etoposide—lung cancer	9.94e-05	0.000836	CcSEcCtD
Propranolol—Dyspnoea—Etoposide—lung cancer	9.87e-05	0.00083	CcSEcCtD
Propranolol—Somnolence—Etoposide—lung cancer	9.84e-05	0.000828	CcSEcCtD
Propranolol—Cough—Docetaxel—lung cancer	9.83e-05	0.000828	CcSEcCtD
Propranolol—Insomnia—Paclitaxel—lung cancer	9.81e-05	0.000826	CcSEcCtD
Propranolol—Hypersensitivity—Irinotecan—lung cancer	9.8e-05	0.000825	CcSEcCtD
Propranolol—Convulsion—Docetaxel—lung cancer	9.76e-05	0.000822	CcSEcCtD
Propranolol—Paraesthesia—Paclitaxel—lung cancer	9.74e-05	0.00082	CcSEcCtD
Propranolol—Bronchitis—Doxorubicin—lung cancer	9.71e-05	0.000817	CcSEcCtD
Propranolol—Agranulocytosis—Methotrexate—lung cancer	9.7e-05	0.000816	CcSEcCtD
Propranolol—Dyspnoea—Paclitaxel—lung cancer	9.67e-05	0.000814	CcSEcCtD
Propranolol—Somnolence—Paclitaxel—lung cancer	9.65e-05	0.000812	CcSEcCtD
Propranolol—Decreased appetite—Etoposide—lung cancer	9.62e-05	0.00081	CcSEcCtD
Propranolol—Nausea—Vinorelbine—lung cancer	9.58e-05	0.000806	CcSEcCtD
Propranolol—Gastrointestinal disorder—Etoposide—lung cancer	9.55e-05	0.000804	CcSEcCtD
Propranolol—Dyspepsia—Paclitaxel—lung cancer	9.55e-05	0.000804	CcSEcCtD
Propranolol—Body temperature increased—Cisplatin—lung cancer	9.55e-05	0.000804	CcSEcCtD
Propranolol—Asthenia—Irinotecan—lung cancer	9.55e-05	0.000803	CcSEcCtD
Propranolol—Fatigue—Etoposide—lung cancer	9.54e-05	0.000803	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	9.53e-05	0.000802	CcSEcCtD
Propranolol—Pain—Etoposide—lung cancer	9.46e-05	0.000796	CcSEcCtD
Propranolol—Constipation—Etoposide—lung cancer	9.46e-05	0.000796	CcSEcCtD
Propranolol—Neutropenia—Doxorubicin—lung cancer	9.44e-05	0.000794	CcSEcCtD
Propranolol—Decreased appetite—Paclitaxel—lung cancer	9.43e-05	0.000794	CcSEcCtD
Propranolol—Gastrointestinal disorder—Paclitaxel—lung cancer	9.37e-05	0.000788	CcSEcCtD
Propranolol—Fatigue—Paclitaxel—lung cancer	9.36e-05	0.000787	CcSEcCtD
Propranolol—Asthenia—Gemcitabine—lung cancer	9.3e-05	0.000783	CcSEcCtD
Propranolol—Pain—Paclitaxel—lung cancer	9.28e-05	0.000781	CcSEcCtD
Propranolol—Constipation—Paclitaxel—lung cancer	9.28e-05	0.000781	CcSEcCtD
Propranolol—Pharyngitis—Methotrexate—lung cancer	9.26e-05	0.000779	CcSEcCtD
Propranolol—Anaphylactic shock—Docetaxel—lung cancer	9.2e-05	0.000774	CcSEcCtD
Propranolol—Infection—Docetaxel—lung cancer	9.14e-05	0.000769	CcSEcCtD
Propranolol—Diarrhoea—Irinotecan—lung cancer	9.1e-05	0.000766	CcSEcCtD
Propranolol—Gastrointestinal pain—Etoposide—lung cancer	9.05e-05	0.000762	CcSEcCtD
Propranolol—Nervous system disorder—Docetaxel—lung cancer	9.02e-05	0.000759	CcSEcCtD
Propranolol—Infestation NOS—Doxorubicin—lung cancer	9e-05	0.000757	CcSEcCtD
Propranolol—Infestation—Doxorubicin—lung cancer	9e-05	0.000757	CcSEcCtD
Propranolol—Visual impairment—Methotrexate—lung cancer	8.99e-05	0.000757	CcSEcCtD
Propranolol—Skin disorder—Docetaxel—lung cancer	8.93e-05	0.000752	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Doxorubicin—lung cancer	8.92e-05	0.000751	CcSEcCtD
Propranolol—Hypersensitivity—Cisplatin—lung cancer	8.9e-05	0.000749	CcSEcCtD
Propranolol—Gastrointestinal pain—Paclitaxel—lung cancer	8.87e-05	0.000747	CcSEcCtD
Propranolol—Diarrhoea—Gemcitabine—lung cancer	8.87e-05	0.000746	CcSEcCtD
Propranolol—Erythema multiforme—Methotrexate—lung cancer	8.82e-05	0.000742	CcSEcCtD
Propranolol—Dizziness—Irinotecan—lung cancer	8.8e-05	0.00074	CcSEcCtD
Propranolol—Urticaria—Etoposide—lung cancer	8.79e-05	0.00074	CcSEcCtD
Propranolol—Abdominal pain—Etoposide—lung cancer	8.75e-05	0.000736	CcSEcCtD
Propranolol—Body temperature increased—Etoposide—lung cancer	8.75e-05	0.000736	CcSEcCtD
Propranolol—Asthenia—Cisplatin—lung cancer	8.67e-05	0.000729	CcSEcCtD
Propranolol—Cardiac disorder—Methotrexate—lung cancer	8.66e-05	0.000729	CcSEcCtD
Propranolol—Urticaria—Paclitaxel—lung cancer	8.62e-05	0.000725	CcSEcCtD
Propranolol—Abdominal pain—Paclitaxel—lung cancer	8.58e-05	0.000722	CcSEcCtD
Propranolol—Body temperature increased—Paclitaxel—lung cancer	8.58e-05	0.000722	CcSEcCtD
Propranolol—Vomiting—Irinotecan—lung cancer	8.46e-05	0.000712	CcSEcCtD
Propranolol—Agranulocytosis—Doxorubicin—lung cancer	8.4e-05	0.000707	CcSEcCtD
Propranolol—Rash—Irinotecan—lung cancer	8.39e-05	0.000706	CcSEcCtD
Propranolol—Dermatitis—Irinotecan—lung cancer	8.38e-05	0.000705	CcSEcCtD
Propranolol—Insomnia—Docetaxel—lung cancer	8.32e-05	0.0007	CcSEcCtD
Propranolol—Diarrhoea—Cisplatin—lung cancer	8.27e-05	0.000696	CcSEcCtD
Propranolol—Paraesthesia—Docetaxel—lung cancer	8.26e-05	0.000695	CcSEcCtD
Propranolol—Alopecia—Methotrexate—lung cancer	8.24e-05	0.000694	CcSEcCtD
Propranolol—Vomiting—Gemcitabine—lung cancer	8.24e-05	0.000693	CcSEcCtD
Propranolol—Bradycardia—Doxorubicin—lung cancer	8.22e-05	0.000692	CcSEcCtD
Propranolol—Dyspnoea—Docetaxel—lung cancer	8.2e-05	0.00069	CcSEcCtD
Propranolol—Somnolence—Docetaxel—lung cancer	8.18e-05	0.000688	CcSEcCtD
Propranolol—Mental disorder—Methotrexate—lung cancer	8.17e-05	0.000688	CcSEcCtD
Propranolol—Rash—Gemcitabine—lung cancer	8.17e-05	0.000688	CcSEcCtD
Propranolol—Dermatitis—Gemcitabine—lung cancer	8.16e-05	0.000687	CcSEcCtD
Propranolol—Hypersensitivity—Etoposide—lung cancer	8.15e-05	0.000686	CcSEcCtD
Propranolol—Propafenone—ABCB1—lung cancer	8.15e-05	0.045	CrCbGaD
Propranolol—Erythema—Methotrexate—lung cancer	8.12e-05	0.000684	CcSEcCtD
Propranolol—Dyspepsia—Docetaxel—lung cancer	8.1e-05	0.000681	CcSEcCtD
Propranolol—Pharyngitis—Doxorubicin—lung cancer	8.02e-05	0.000675	CcSEcCtD
Propranolol—Decreased appetite—Docetaxel—lung cancer	8e-05	0.000673	CcSEcCtD
Propranolol—Hypersensitivity—Paclitaxel—lung cancer	7.99e-05	0.000673	CcSEcCtD
Propranolol—Gastrointestinal disorder—Docetaxel—lung cancer	7.94e-05	0.000668	CcSEcCtD
Propranolol—Asthenia—Etoposide—lung cancer	7.94e-05	0.000668	CcSEcCtD
Propranolol—Fatigue—Docetaxel—lung cancer	7.93e-05	0.000667	CcSEcCtD
Propranolol—Nausea—Irinotecan—lung cancer	7.9e-05	0.000665	CcSEcCtD
Propranolol—Pain—Docetaxel—lung cancer	7.86e-05	0.000662	CcSEcCtD
Propranolol—Constipation—Docetaxel—lung cancer	7.86e-05	0.000662	CcSEcCtD
Propranolol—Visual impairment—Doxorubicin—lung cancer	7.79e-05	0.000655	CcSEcCtD
Propranolol—Asthenia—Paclitaxel—lung cancer	7.79e-05	0.000655	CcSEcCtD
Propranolol—Nausea—Gemcitabine—lung cancer	7.7e-05	0.000648	CcSEcCtD
Propranolol—Vomiting—Cisplatin—lung cancer	7.68e-05	0.000646	CcSEcCtD
Propranolol—Erythema multiforme—Doxorubicin—lung cancer	7.64e-05	0.000643	CcSEcCtD
Propranolol—Rash—Cisplatin—lung cancer	7.62e-05	0.000641	CcSEcCtD
Propranolol—Dermatitis—Cisplatin—lung cancer	7.61e-05	0.00064	CcSEcCtD
Propranolol—Diarrhoea—Etoposide—lung cancer	7.57e-05	0.000637	CcSEcCtD
Propranolol—Gastrointestinal pain—Docetaxel—lung cancer	7.52e-05	0.000633	CcSEcCtD
Propranolol—Cardiac disorder—Doxorubicin—lung cancer	7.5e-05	0.000631	CcSEcCtD
Propranolol—Diarrhoea—Paclitaxel—lung cancer	7.42e-05	0.000625	CcSEcCtD
Propranolol—Carvedilol—ABCB1—lung cancer	7.34e-05	0.0405	CrCbGaD
Propranolol—Dizziness—Etoposide—lung cancer	7.32e-05	0.000616	CcSEcCtD
Propranolol—Vertigo—Methotrexate—lung cancer	7.3e-05	0.000614	CcSEcCtD
Propranolol—Abdominal pain—Docetaxel—lung cancer	7.27e-05	0.000612	CcSEcCtD
Propranolol—Body temperature increased—Docetaxel—lung cancer	7.27e-05	0.000612	CcSEcCtD
Propranolol—Dizziness—Paclitaxel—lung cancer	7.18e-05	0.000604	CcSEcCtD
Propranolol—Nausea—Cisplatin—lung cancer	7.18e-05	0.000604	CcSEcCtD
Propranolol—Alopecia—Doxorubicin—lung cancer	7.14e-05	0.000601	CcSEcCtD
Propranolol—Cough—Methotrexate—lung cancer	7.09e-05	0.000596	CcSEcCtD
Propranolol—Mental disorder—Doxorubicin—lung cancer	7.08e-05	0.000596	CcSEcCtD
Propranolol—Convulsion—Methotrexate—lung cancer	7.04e-05	0.000592	CcSEcCtD
Propranolol—Vomiting—Etoposide—lung cancer	7.04e-05	0.000592	CcSEcCtD
Propranolol—Erythema—Doxorubicin—lung cancer	7.03e-05	0.000592	CcSEcCtD
Propranolol—Rash—Etoposide—lung cancer	6.98e-05	0.000587	CcSEcCtD
Propranolol—Dermatitis—Etoposide—lung cancer	6.97e-05	0.000587	CcSEcCtD
Propranolol—Vomiting—Paclitaxel—lung cancer	6.9e-05	0.000581	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	6.87e-05	0.000578	CcSEcCtD
Propranolol—Rash—Paclitaxel—lung cancer	6.84e-05	0.000576	CcSEcCtD
Propranolol—Dermatitis—Paclitaxel—lung cancer	6.84e-05	0.000575	CcSEcCtD
Propranolol—Hypersensitivity—Docetaxel—lung cancer	6.78e-05	0.00057	CcSEcCtD
Propranolol—Anaphylactic shock—Methotrexate—lung cancer	6.63e-05	0.000558	CcSEcCtD
Propranolol—Asthenia—Docetaxel—lung cancer	6.6e-05	0.000555	CcSEcCtD
Propranolol—Infection—Methotrexate—lung cancer	6.59e-05	0.000554	CcSEcCtD
Propranolol—Nausea—Etoposide—lung cancer	6.57e-05	0.000553	CcSEcCtD
Propranolol—Nervous system disorder—Methotrexate—lung cancer	6.5e-05	0.000547	CcSEcCtD
Propranolol—Agitation—Doxorubicin—lung cancer	6.46e-05	0.000544	CcSEcCtD
Propranolol—Nausea—Paclitaxel—lung cancer	6.45e-05	0.000542	CcSEcCtD
Propranolol—Skin disorder—Methotrexate—lung cancer	6.44e-05	0.000542	CcSEcCtD
Propranolol—Vertigo—Doxorubicin—lung cancer	6.32e-05	0.000532	CcSEcCtD
Propranolol—Diarrhoea—Docetaxel—lung cancer	6.29e-05	0.00053	CcSEcCtD
Propranolol—Cough—Doxorubicin—lung cancer	6.14e-05	0.000516	CcSEcCtD
Propranolol—Convulsion—Doxorubicin—lung cancer	6.09e-05	0.000513	CcSEcCtD
Propranolol—Dizziness—Docetaxel—lung cancer	6.08e-05	0.000512	CcSEcCtD
Propranolol—Insomnia—Methotrexate—lung cancer	6e-05	0.000505	CcSEcCtD
Propranolol—Paraesthesia—Methotrexate—lung cancer	5.95e-05	0.000501	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	5.95e-05	0.0005	CcSEcCtD
Propranolol—Dyspnoea—Methotrexate—lung cancer	5.91e-05	0.000497	CcSEcCtD
Propranolol—Somnolence—Methotrexate—lung cancer	5.89e-05	0.000496	CcSEcCtD
Propranolol—Vomiting—Docetaxel—lung cancer	5.85e-05	0.000492	CcSEcCtD
Propranolol—Dyspepsia—Methotrexate—lung cancer	5.84e-05	0.000491	CcSEcCtD
Propranolol—Rash—Docetaxel—lung cancer	5.8e-05	0.000488	CcSEcCtD
Propranolol—Dermatitis—Docetaxel—lung cancer	5.79e-05	0.000488	CcSEcCtD
Propranolol—Decreased appetite—Methotrexate—lung cancer	5.76e-05	0.000485	CcSEcCtD
Propranolol—Anaphylactic shock—Doxorubicin—lung cancer	5.74e-05	0.000483	CcSEcCtD
Propranolol—Gastrointestinal disorder—Methotrexate—lung cancer	5.72e-05	0.000482	CcSEcCtD
Propranolol—Fatigue—Methotrexate—lung cancer	5.72e-05	0.000481	CcSEcCtD
Propranolol—Infection—Doxorubicin—lung cancer	5.7e-05	0.00048	CcSEcCtD
Propranolol—Pain—Methotrexate—lung cancer	5.67e-05	0.000477	CcSEcCtD
Propranolol—Nervous system disorder—Doxorubicin—lung cancer	5.63e-05	0.000474	CcSEcCtD
Propranolol—Skin disorder—Doxorubicin—lung cancer	5.58e-05	0.000469	CcSEcCtD
Propranolol—Nausea—Docetaxel—lung cancer	5.46e-05	0.00046	CcSEcCtD
Propranolol—Gastrointestinal pain—Methotrexate—lung cancer	5.42e-05	0.000456	CcSEcCtD
Propranolol—Urticaria—Methotrexate—lung cancer	5.27e-05	0.000443	CcSEcCtD
Propranolol—Abdominal pain—Methotrexate—lung cancer	5.24e-05	0.000441	CcSEcCtD
Propranolol—Body temperature increased—Methotrexate—lung cancer	5.24e-05	0.000441	CcSEcCtD
Propranolol—Insomnia—Doxorubicin—lung cancer	5.19e-05	0.000437	CcSEcCtD
Propranolol—Paraesthesia—Doxorubicin—lung cancer	5.15e-05	0.000434	CcSEcCtD
Propranolol—Dyspnoea—Doxorubicin—lung cancer	5.12e-05	0.000431	CcSEcCtD
Propranolol—Somnolence—Doxorubicin—lung cancer	5.1e-05	0.000429	CcSEcCtD
Propranolol—Dyspepsia—Doxorubicin—lung cancer	5.05e-05	0.000425	CcSEcCtD
Propranolol—Decreased appetite—Doxorubicin—lung cancer	4.99e-05	0.00042	CcSEcCtD
Propranolol—Gastrointestinal disorder—Doxorubicin—lung cancer	4.96e-05	0.000417	CcSEcCtD
Propranolol—Fatigue—Doxorubicin—lung cancer	4.95e-05	0.000416	CcSEcCtD
Propranolol—Pain—Doxorubicin—lung cancer	4.91e-05	0.000413	CcSEcCtD
Propranolol—Constipation—Doxorubicin—lung cancer	4.91e-05	0.000413	CcSEcCtD
Propranolol—Hypersensitivity—Methotrexate—lung cancer	4.88e-05	0.000411	CcSEcCtD
Propranolol—Asthenia—Methotrexate—lung cancer	4.76e-05	0.0004	CcSEcCtD
Propranolol—Gastrointestinal pain—Doxorubicin—lung cancer	4.69e-05	0.000395	CcSEcCtD
Propranolol—Urticaria—Doxorubicin—lung cancer	4.56e-05	0.000384	CcSEcCtD
Propranolol—Abdominal pain—Doxorubicin—lung cancer	4.54e-05	0.000382	CcSEcCtD
Propranolol—Body temperature increased—Doxorubicin—lung cancer	4.54e-05	0.000382	CcSEcCtD
Propranolol—Diarrhoea—Methotrexate—lung cancer	4.54e-05	0.000382	CcSEcCtD
Propranolol—Dizziness—Methotrexate—lung cancer	4.38e-05	0.000369	CcSEcCtD
Propranolol—Hypersensitivity—Doxorubicin—lung cancer	4.23e-05	0.000356	CcSEcCtD
Propranolol—Vomiting—Methotrexate—lung cancer	4.21e-05	0.000355	CcSEcCtD
Propranolol—Rash—Methotrexate—lung cancer	4.18e-05	0.000352	CcSEcCtD
Propranolol—Dermatitis—Methotrexate—lung cancer	4.18e-05	0.000351	CcSEcCtD
Propranolol—Asthenia—Doxorubicin—lung cancer	4.12e-05	0.000347	CcSEcCtD
Propranolol—Nausea—Methotrexate—lung cancer	3.94e-05	0.000331	CcSEcCtD
Propranolol—Diarrhoea—Doxorubicin—lung cancer	3.93e-05	0.000331	CcSEcCtD
Propranolol—Dizziness—Doxorubicin—lung cancer	3.8e-05	0.000319	CcSEcCtD
Propranolol—Vomiting—Doxorubicin—lung cancer	3.65e-05	0.000307	CcSEcCtD
Propranolol—Rash—Doxorubicin—lung cancer	3.62e-05	0.000305	CcSEcCtD
Propranolol—Dermatitis—Doxorubicin—lung cancer	3.62e-05	0.000304	CcSEcCtD
Propranolol—Nausea—Doxorubicin—lung cancer	3.41e-05	0.000287	CcSEcCtD
Propranolol—CYP2D6—Metabolism—CAT—lung cancer	3.6e-06	4.58e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—HPGDS—lung cancer	3.59e-06	4.58e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ENO2—lung cancer	3.59e-06	4.58e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CDKN1A—lung cancer	3.59e-06	4.57e-05	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—PIK3CA—lung cancer	3.58e-06	4.57e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PTEN—lung cancer	3.58e-06	4.56e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PPP2R1B—lung cancer	3.57e-06	4.55e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CG—lung cancer	3.55e-06	4.52e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—KRAS—lung cancer	3.54e-06	4.51e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.51e-06	4.47e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CYP1A1—lung cancer	3.5e-06	4.46e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ABCB1—lung cancer	3.5e-06	4.45e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—AKT1—lung cancer	3.49e-06	4.45e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GSTT1—lung cancer	3.49e-06	4.44e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ERCC2—lung cancer	3.47e-06	4.42e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GCLC—lung cancer	3.45e-06	4.39e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP2A6—lung cancer	3.45e-06	4.39e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—TYMS—lung cancer	3.44e-06	4.37e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CYP1A1—lung cancer	3.42e-06	4.35e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—EP300—lung cancer	3.41e-06	4.35e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—PIK3CA—lung cancer	3.4e-06	4.33e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GSTM1—lung cancer	3.4e-06	4.32e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MDM2—lung cancer	3.39e-06	4.32e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ERCC2—lung cancer	3.39e-06	4.31e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—PIK3CA—lung cancer	3.39e-06	4.31e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—STK11—lung cancer	3.38e-06	4.31e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—RAF1—lung cancer	3.38e-06	4.3e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—POMC—lung cancer	3.38e-06	4.3e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CG—lung cancer	3.35e-06	4.27e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—ERBB2—lung cancer	3.34e-06	4.26e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—PIK3CA—lung cancer	3.33e-06	4.24e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—SRC—lung cancer	3.32e-06	4.23e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MDM2—lung cancer	3.32e-06	4.22e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—RAF1—lung cancer	3.3e-06	4.21e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PIK3CB—lung cancer	3.3e-06	4.2e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MTOR—lung cancer	3.3e-06	4.2e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—CREBBP—lung cancer	3.29e-06	4.19e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TP53—lung cancer	3.28e-06	4.17e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—ERBB2—lung cancer	3.27e-06	4.16e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ENO1—lung cancer	3.27e-06	4.16e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—PIK3CA—lung cancer	3.25e-06	4.15e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PTEN—lung cancer	3.25e-06	4.14e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PTEN—lung cancer	3.24e-06	4.13e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MDM2—lung cancer	3.24e-06	4.13e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—VEGFA—lung cancer	3.23e-06	4.12e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—RAF1—lung cancer	3.23e-06	4.11e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MTOR—lung cancer	3.23e-06	4.11e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PIK3CB—lung cancer	3.23e-06	4.11e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CYP1A1—lung cancer	3.22e-06	4.1e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—STAT3—lung cancer	3.2e-06	4.08e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—ERBB2—lung cancer	3.2e-06	4.07e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ERCC2—lung cancer	3.19e-06	4.07e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—NRAS—lung cancer	3.19e-06	4.07e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—POMC—lung cancer	3.19e-06	4.06e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.18e-06	4.04e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CXCL8—lung cancer	3.17e-06	4.04e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PIK3CB—lung cancer	3.15e-06	4.02e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MTOR—lung cancer	3.15e-06	4.02e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—HRAS—lung cancer	3.15e-06	4.01e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—HRAS—lung cancer	3.13e-06	3.99e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GSTP1—lung cancer	3.13e-06	3.99e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CD—lung cancer	3.12e-06	3.97e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—CREBBP—lung cancer	3.11e-06	3.96e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CXCL8—lung cancer	3.1e-06	3.95e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—EP300—lung cancer	3.1e-06	3.94e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—EP300—lung cancer	3.09e-06	3.94e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—HRAS—lung cancer	3.08e-06	3.92e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—ALB—lung cancer	3.08e-06	3.92e-05	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—AKT1—lung cancer	3.06e-06	3.9e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MAPK3—lung cancer	3.06e-06	3.89e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CAT—lung cancer	3.05e-06	3.88e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CASP3—lung cancer	3.03e-06	3.86e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CXCL8—lung cancer	3.03e-06	3.86e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.03e-06	3.86e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL2—lung cancer	3.03e-06	3.86e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—IL6—lung cancer	3.01e-06	3.84e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—HRAS—lung cancer	3.01e-06	3.84e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—APOA1—lung cancer	3e-06	3.82e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IL6—lung cancer	3e-06	3.82e-05	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—AKT1—lung cancer	2.99e-06	3.81e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MYC—lung cancer	2.97e-06	3.79e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CASP3—lung cancer	2.97e-06	3.78e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ABCB1—lung cancer	2.96e-06	3.77e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL2—lung cancer	2.96e-06	3.77e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CCND1—lung cancer	2.95e-06	3.76e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—IL6—lung cancer	2.95e-06	3.75e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—JUN—lung cancer	2.95e-06	3.75e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CD—lung cancer	2.94e-06	3.75e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—APOA1—lung cancer	2.93e-06	3.73e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP2E1—lung cancer	2.93e-06	3.73e-05	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—AKT1—lung cancer	2.93e-06	3.73e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—TYMS—lung cancer	2.91e-06	3.71e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—EGFR—lung cancer	2.91e-06	3.7e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—ALB—lung cancer	2.91e-06	3.7e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CASP3—lung cancer	2.9e-06	3.69e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL2—lung cancer	2.9e-06	3.69e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NQO1—lung cancer	2.9e-06	3.69e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CCND1—lung cancer	2.89e-06	3.68e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—IL6—lung cancer	2.88e-06	3.67e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—JUN—lung cancer	2.88e-06	3.67e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GSTM1—lung cancer	2.88e-06	3.66e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.88e-06	3.66e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MMP9—lung cancer	2.87e-06	3.65e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CDKN1A—lung cancer	2.86e-06	3.64e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PTEN—lung cancer	2.85e-06	3.63e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CCND1—lung cancer	2.82e-06	3.6e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—JUN—lung cancer	2.82e-06	3.59e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MMP9—lung cancer	2.8e-06	3.57e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CDKN1A—lung cancer	2.79e-06	3.56e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PTEN—lung cancer	2.79e-06	3.55e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—AKT1—lung cancer	2.78e-06	3.54e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—AKT1—lung cancer	2.77e-06	3.52e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—APOA1—lung cancer	2.76e-06	3.52e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—KRAS—lung cancer	2.75e-06	3.5e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MMP9—lung cancer	2.74e-06	3.49e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CG—lung cancer	2.74e-06	3.49e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CDKN1A—lung cancer	2.73e-06	3.48e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CYP1A1—lung cancer	2.73e-06	3.47e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PTEN—lung cancer	2.73e-06	3.47e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—AKT1—lung cancer	2.72e-06	3.46e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—EP300—lung cancer	2.72e-06	3.46e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CB—lung cancer	2.72e-06	3.46e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ERCC2—lung cancer	2.7e-06	3.44e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PTGS2—lung cancer	2.69e-06	3.43e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CG—lung cancer	2.68e-06	3.41e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—AKT1—lung cancer	2.66e-06	3.39e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—EP300—lung cancer	2.66e-06	3.39e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—SRC—lung cancer	2.64e-06	3.37e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—STK11—lung cancer	2.61e-06	3.33e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—POMC—lung cancer	2.61e-06	3.32e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—EP300—lung cancer	2.6e-06	3.31e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—SRC—lung cancer	2.59e-06	3.29e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—VEGFA—lung cancer	2.57e-06	3.28e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CB—lung cancer	2.57e-06	3.27e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—STAT3—lung cancer	2.55e-06	3.25e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—POMC—lung cancer	2.55e-06	3.24e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PTGS2—lung cancer	2.54e-06	3.24e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—NRAS—lung cancer	2.54e-06	3.24e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CREBBP—lung cancer	2.54e-06	3.24e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—SRC—lung cancer	2.53e-06	3.22e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PIK3CA—lung cancer	2.52e-06	3.21e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CG—lung cancer	2.52e-06	3.21e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—VEGFA—lung cancer	2.52e-06	3.21e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—STAT3—lung cancer	2.49e-06	3.17e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—NRAS—lung cancer	2.49e-06	3.17e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CREBBP—lung cancer	2.48e-06	3.16e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—VEGFA—lung cancer	2.46e-06	3.14e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TP53—lung cancer	2.44e-06	3.11e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—STAT3—lung cancer	2.44e-06	3.1e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MAPK3—lung cancer	2.43e-06	3.1e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—NRAS—lung cancer	2.43e-06	3.1e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GSTP1—lung cancer	2.42e-06	3.08e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CD—lung cancer	2.41e-06	3.07e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—POMC—lung cancer	2.4e-06	3.06e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MAPK3—lung cancer	2.38e-06	3.03e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ALB—lung cancer	2.38e-06	3.03e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MYC—lung cancer	2.37e-06	3.02e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CD—lung cancer	2.35e-06	3e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CAT—lung cancer	2.35e-06	2.99e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PTEN—lung cancer	2.35e-06	2.99e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—APOA1—lung cancer	2.34e-06	2.98e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CREBBP—lung cancer	2.34e-06	2.98e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—HRAS—lung cancer	2.34e-06	2.97e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MAPK3—lung cancer	2.33e-06	2.97e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ALB—lung cancer	2.32e-06	2.96e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MYC—lung cancer	2.32e-06	2.95e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—EGFR—lung cancer	2.32e-06	2.95e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PIK3CA—lung cancer	2.29e-06	2.92e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PIK3CA—lung cancer	2.29e-06	2.91e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ABCB1—lung cancer	2.29e-06	2.91e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—EGFR—lung cancer	2.27e-06	2.89e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MYC—lung cancer	2.27e-06	2.88e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—TYMS—lung cancer	2.25e-06	2.86e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.24e-06	2.85e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—EP300—lung cancer	2.24e-06	2.85e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IL6—lung cancer	2.24e-06	2.85e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GSTM1—lung cancer	2.22e-06	2.83e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PTEN—lung cancer	2.22e-06	2.82e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CD—lung cancer	2.22e-06	2.82e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—EGFR—lung cancer	2.22e-06	2.82e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—KRAS—lung cancer	2.19e-06	2.79e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ALB—lung cancer	2.19e-06	2.79e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—KRAS—lung cancer	2.14e-06	2.73e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CG—lung cancer	2.14e-06	2.72e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—EP300—lung cancer	2.12e-06	2.69e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP1A1—lung cancer	2.1e-06	2.68e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CB—lung cancer	2.1e-06	2.68e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—KRAS—lung cancer	2.09e-06	2.67e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ERCC2—lung cancer	2.09e-06	2.66e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PTGS2—lung cancer	2.08e-06	2.65e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—AKT1—lung cancer	2.06e-06	2.63e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CB—lung cancer	2.05e-06	2.61e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—POMC—lung cancer	2.03e-06	2.59e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PTGS2—lung cancer	2.03e-06	2.59e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PIK3CA—lung cancer	2.01e-06	2.56e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CREBBP—lung cancer	1.98e-06	2.52e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PIK3CA—lung cancer	1.97e-06	2.5e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TP53—lung cancer	1.94e-06	2.48e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CB—lung cancer	1.93e-06	2.46e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PIK3CA—lung cancer	1.92e-06	2.45e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PTGS2—lung cancer	1.91e-06	2.44e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TP53—lung cancer	1.9e-06	2.42e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CD—lung cancer	1.88e-06	2.39e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—AKT1—lung cancer	1.87e-06	2.38e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—AKT1—lung cancer	1.87e-06	2.38e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TP53—lung cancer	1.86e-06	2.37e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—HRAS—lung cancer	1.86e-06	2.37e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ALB—lung cancer	1.85e-06	2.36e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—HRAS—lung cancer	1.82e-06	2.32e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PTEN—lung cancer	1.82e-06	2.31e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—APOA1—lung cancer	1.81e-06	2.3e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL6—lung cancer	1.78e-06	2.27e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—HRAS—lung cancer	1.78e-06	2.27e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PTEN—lung cancer	1.77e-06	2.26e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL6—lung cancer	1.74e-06	2.22e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—EP300—lung cancer	1.73e-06	2.2e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL6—lung cancer	1.7e-06	2.17e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—EP300—lung cancer	1.69e-06	2.15e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PTEN—lung cancer	1.67e-06	2.13e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CA—lung cancer	1.66e-06	2.11e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CG—lung cancer	1.65e-06	2.1e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—AKT1—lung cancer	1.64e-06	2.09e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CB—lung cancer	1.64e-06	2.08e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PTGS2—lung cancer	1.62e-06	2.07e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—AKT1—lung cancer	1.61e-06	2.05e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—EP300—lung cancer	1.59e-06	2.03e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—AKT1—lung cancer	1.57e-06	2e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—POMC—lung cancer	1.57e-06	2e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CA—lung cancer	1.56e-06	1.99e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CREBBP—lung cancer	1.53e-06	1.95e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CD—lung cancer	1.45e-06	1.85e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ALB—lung cancer	1.43e-06	1.82e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PTEN—lung cancer	1.41e-06	1.8e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—AKT1—lung cancer	1.35e-06	1.72e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—EP300—lung cancer	1.35e-06	1.72e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CA—lung cancer	1.28e-06	1.63e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—AKT1—lung cancer	1.28e-06	1.63e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CB—lung cancer	1.26e-06	1.61e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PTGS2—lung cancer	1.25e-06	1.59e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CA—lung cancer	1.25e-06	1.59e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CA—lung cancer	1.18e-06	1.5e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PTEN—lung cancer	1.09e-06	1.39e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—AKT1—lung cancer	1.05e-06	1.33e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—EP300—lung cancer	1.04e-06	1.33e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—AKT1—lung cancer	1.02e-06	1.3e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CA—lung cancer	9.98e-07	1.27e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—AKT1—lung cancer	9.62e-07	1.23e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—AKT1—lung cancer	8.15e-07	1.04e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CA—lung cancer	7.7e-07	9.81e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—AKT1—lung cancer	6.29e-07	8.01e-06	CbGpPWpGaD
